Funding and Investments

Dec 15, 2016
By BioPharm International Editors
DuPont received a grant from the Bill & Melinda Gates Foundation to produce pharmaceutical proteins.
Dec 15, 2016
By BioPharm International Editors
Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.
Dec 14, 2016
By BioPharm International Editors
BMS changes its US geographic footprint with R&D investments and closures.
Nov 16, 2016
By BioPharm International Editors
Despite some progress, pharmaceutical companies have a long way to go in making their products accessible and affordable, this year's study finds.
Nov 04, 2016
By BioPharm International Editors
The company invested more than €250 in production in China.
Nov 01, 2016
By BioPharm International Editors
Oxford Genetics has secured a GBP1 million capital from investment group Mercia Technologies to support its growth strategy in delivering new services for cancer-fighting gene-therapy technologies.
Oct 12, 2016
By BioPharm International Editors
The company invested more than CHF 100 million in a new Delaware manufacturing plant.
Oct 03, 2016
By BioPharm International Editors
The company invested in a new cGMP facility located in Berlin, Germany.
Sep 07, 2016
By BioPharm International Editors
The department gave Moderna $8.2 million to accelerate development of an mRNA-based Zika vaccine.
Jun 15, 2016
BioPharm International
By BioPharm International Editors
Biopharmaceutical contractors continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
native1_300x100
lorem ipsum